A Phase II Multi-center Pilot Study of Concurrent Temozolomide and Whole Brain Irradiation in Lung Cancer and Breast Cancer Patients With Brain Metastases
Status: UNKNOWN
Study type: INTERVENTIONAL
Conditions: Lung Cancer and Breast Cancer Patients With Brain Metastases
Interventions: DRUG: temozolomide 100mg
Sponsor: Far Eastern Memorial Hospital